(1)
Can DPP-4 Enhibitors and SGLT-2 Inhibitors Pleotropic Effects Be Extended to Treat Diabetic Nephropathy?. J. Medicine 2023, 24 (1), 43-49. https://doi.org/10.3329/jom.v24i1.64903.